Brigham and Women’s Hospital Therapeutics (BWH TCRS) CRS

Location	Brigham and Women’s Hospital ACTG Clinical Research Site 15 Francis Street PBBA-4 Boston, MA 02115
CRS Coordinator	Cheryl Keenan ckeenan@bwh.harvard.edu 617-732-5635
CRS Leader	Paul Sax psax@bwh.harvard.edu 617-732-8881
Studies	A5357: A Study of Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) to Maintain Viral Suppression in Adults Living with HIV-1 A5366: Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation with Histone Deacetylase Inhibitors A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) A5332: REPRIEVE Trial A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation (HAILO) A5379: B-Enhancement of HBV vaccination in persons living with HIV (BEe-HIVe): Evaluation of HEPLISAV-B A5359: The LATITUDE Study ACTG A5383: Randomized, Controlled Trial to Evaluate the Anti-inflammatory Efficacy of Letermovir (Prevymis) in Adults with Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive ART and Its Effect on Chronic Inflammation, HIV Persistence, and Other Clinical Outcomes (ELICIT) A5418:Study of Tecovirimat for Human Monkeypox Virus (STOMP)